Hint mode is switched on Switch off
For swift navigation between sections

Passage Bio

PDF download

Choose all Reset all
Download Cancel
Organization name
Passage Bio Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Passage Bio, Inc. operates as a genetic medicines company. The Company develops a portfolio of AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases. Passage Bio serves customers in the State of Pennsylvania.

Awards

News

28/04/2026 Passage Bio: Costs Associated With Exit Or Disposal Activities
20/04/2026 Passage Bio: Regulation Fd Disclosure, Financial Statements And Exhibits
04/03/2026 Passage Bio: Termination Of A Material Definitive Agreement
16/09/2025 Passage Bio: Departure Of Director Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
28/07/2025 Passage Bio: Other Events
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
III q eng
2024
I q eng
II q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0001787297
  • EIN
    82-2729751
Registration is required to get access.